KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Moderna (MRNA) Shares Repurchased (2021 - 2023)

Moderna (MRNA) has disclosed Shares Repurchased for 3 consecutive years, with -$1.0 million as the latest value for Q3 2023.

  • Quarterly Shares Repurchased fell 100.1% to -$1.0 million in Q3 2023 from the year-ago period, while the trailing twelve-month figure was -$1.0 million through Jun 2024, down 100.04% year-over-year, with the annual reading at $2.0 million for FY2025, N/A changed from the prior year.
  • Shares Repurchased for Q3 2023 was -$1.0 million at Moderna, down from $628.0 million in the prior quarter.
  • The five-year high for Shares Repurchased was $1.3 billion in Q2 2022, with the low at -$1.0 million in Q3 2023.
  • Average Shares Repurchased over 3 years is $667.4 million, with a median of $625.5 million recorded in 2022.
  • Peak annual rise in Shares Repurchased hit 15.57% in 2023, while the deepest fall reached 100.1% in 2023.
  • Over 3 years, Shares Repurchased stood at $857.0 million in 2021, then crashed by 53.09% to $402.0 million in 2022, then crashed by 100.25% to -$1.0 million in 2023.
  • According to Business Quant data, Shares Repurchased over the past three periods came in at -$1.0 million, $628.0 million, and $526.0 million for Q3 2023, Q2 2023, and Q1 2023 respectively.